Jürgens H
Klin Padiatr. 1981 May;193(3):254-7. doi: 10.1055/s-2008-1034471.
The German Society of Pediatric Oncology designed a cooperative study (CESS 81) to improve the patients outlook with primary Ewing's sarcoma. Patients are randomized whether or not to receive bleomycin in addition to conventional four drug regimen including vincristine, adriamycin, cyclophosphamide and actinomycin D. For local therapy radiotherapy or surgery can be used alternatively. Patients who received radiotherapy for local control, and show measurable shrinking of the primary tumor under chemotherapy, are randomized to receive 4600 rad or 6000 rad for local control. Patients' accrual is expected to be about 100 patients over 3 years.
德国儿科肿瘤学会设计了一项合作研究(CESS 81),以改善原发性尤因肉瘤患者的预后。患者被随机分组,决定在包括长春新碱、阿霉素、环磷酰胺和放线菌素D在内的传统四联化疗方案基础上是否加用博来霉素。局部治疗可选择放疗或手术。接受放疗以控制局部病灶且在化疗期间原发肿瘤有可测量缩小的患者,被随机分组接受4600拉德或6000拉德的局部放疗剂量以控制局部病灶。预计3年内将招募约100名患者。